FME — Fresenius Medical Care AG Share Price
Last trade - 00:00- €12.21bn
- €22.87bn
- €19.45bn
- 90
- 69
- 95
- 99
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 12.39 | ||
| PEG Ratio (f) | 0.74 | ||
| EPS Growth (f) | 20.07% | ||
| Dividend Yield (f) | 3.22% | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.9 | ||
| Price to Tang. Book | n/a | ||
| Price to Free Cashflow | 7.92 | ||
| Price to Sales | 0.63 | ||
| EV to EBITDA | 7.23 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 5.86% | ||
| Return on Equity | 4.77% | ||
| Operating Margin | 8.11% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | €m | 17,476.56 | 17,859.06 | 17,618.69 | 19,398.02 | 19,453.62 | 19,265.18 | 19,926.81 | 3.29% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | -10.59 | +12.22 | -28.31 | -36.29 | +35.31 | -4.45 | +22.37 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Fresenius Medical Care AG, formerly Fresenius Medical Care AG & Co. KGaA is a Germany-based Company, which is a kidney dialysis institute. The Company provides dialysis care and related services to persons suffering from end-stage renal disease (ESRD), as well as other healthcare services. The Company also develops and manufactures a wide variety of health care products, which includes dialysis and non-dialysis products. Its dialysis products include hemodialysis machines, peritoneal cyclers, dialyzers, peritoneal solutions and granulates, bloodlines, renal pharmaceuticals and systems for water treatment. Its non-dialysis products include acute cardiopulmonary and apheresis products. The Company supplies dialysis clinics it owns, operates or manages with a broad range of products, and sells dialysis products to other dialysis service providers.
Directors
- Dieter Schenk CSU (69)
- Rice Powell CMG (66)
- Ben Lipps NEC (81)
- Rolf Classon VSU (76)
- Helen Giza CFO (52)
- Olaf Schermeier VRD (48)
- Harry de Wit MGB (58)
- Frank Maddux MGB (62)
- Katarzyna Mazur-Hofsaess MGB (57)
- William Valle MGB (61)
- Kent Wanzek MGB (61)
- William Johnston IND (77)
- Dorothea Wenzel IND (52)
- Pascale Witz IND (54)
- Gregor Zuend SUB (62)
- Last Annual
- December 31st, 2023
- Last Interim
- September 30th, 2024
- Incorporated
- February 10th, 2006
- Public Since
- October 2nd, 1996
- No. of Employees
- 113,079
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
- XETRA
- Shares in Issue
- 293,413,449
- Address
- Else-Kroener-Strasse 1, BAD HOMBURG VOR DER HOHE, 61352
- Web
- https://www.freseniusmedicalcare.com/
- Phone
- +49 61726090
- Contact
- Dominik Heger
- Auditors
- PricewaterhouseCoopers GmbH
Latest News for FME
Upcoming Events for FME
Fresenius Medical Care AG at Berenberg European Conference
Fresenius Medical Care AG Corporate Governance Virtual Roadshow
Fresenius Medical Care AG at JPMorgan Healthcare Conference
Full Year 2024 Fresenius Medical Care AG Earnings Release
Full Year 2024 Fresenius Medical Care AG Earnings Call
Q1 2025 Fresenius Medical Care AG Earnings Release
Q1 2025 Fresenius Medical Care AG Earnings Call
Fresenius Medical Care AG Annual Shareholders Meeting
Similar to FME
FAQ
As of Today at 19:44 UTC, shares in Fresenius Medical Care AG are trading at €41.60. This share price information is delayed by 15 minutes.
Shares in Fresenius Medical Care AG last closed at €41.60 and the price had moved by +10.55% over the past 365 days. In terms of relative price strength the Fresenius Medical Care AG share price has outperformed the FTSE Global All Cap Index by +0.53% over the past year.
The overall consensus recommendation for Fresenius Medical Care AG is Hold. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Fresenius Medical Care AG dividend yield is 2.86% based on the trailing twelve month period.
Last year, Fresenius Medical Care AG paid a total dividend of €1.19, and it currently has a trailing dividend yield of 2.86%. We do not have any data on when Fresenius Medical Care AG is to next pay dividends.
We do not have data on when Fresenius Medical Care AG is to next pay dividends. The historic dividend yield on Fresenius Medical Care AG shares is currently 2.86%.
To buy shares in Fresenius Medical Care AG you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of €41.60, shares in Fresenius Medical Care AG had a market capitalisation of €12.21bn.
Here are the trading details for Fresenius Medical Care AG:
- Country of listing: Germany
- Exchange: GER
- Ticker Symbol: FME
Based on an overall assessment of its quality, value and momentum Fresenius Medical Care AG is currently classified as a Super Stock. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Fresenius Medical Care AG is €38.90. That is 6.49% below the last closing price of €41.60.
Analysts covering Fresenius Medical Care AG currently have a consensus Earnings Per Share (EPS) forecast of €2.79 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Fresenius Medical Care AG. Over the past six months, its share price has outperformed the FTSE Global All Cap Index by +7.79%.
As of the last closing price of €41.60, shares in Fresenius Medical Care AG were trading +11.92% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Fresenius Medical Care AG PE ratio based on its reported earnings over the past 12 months is 12.39. The shares last closed at €41.60.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Fresenius Medical Care AG's management team is headed by:
- Dieter Schenk - CSU
- Rice Powell - CMG
- Ben Lipps - NEC
- Rolf Classon - VSU
- Helen Giza - CFO
- Olaf Schermeier - VRD
- Harry de Wit - MGB
- Frank Maddux - MGB
- Katarzyna Mazur-Hofsaess - MGB
- William Valle - MGB
- Kent Wanzek - MGB
- William Johnston - IND
- Dorothea Wenzel - IND
- Pascale Witz - IND
- Gregor Zuend - SUB